Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques

about

Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques

Item

http://www.wikidata.org/entity/Q56334431

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 28 June 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Improved CNS exposure to tocil ...... inistration in rhesus macaques

@en

Improved CNS exposure to tocil ...... inistration in rhesus macaques

@nl

type

Item

label

Improved CNS exposure to tocil ...... inistration in rhesus macaques

@en

Improved CNS exposure to tocil ...... inistration in rhesus macaques

@nl

prefLabel

Improved CNS exposure to tocil ...... inistration in rhesus macaques

@en

Improved CNS exposure to tocil ...... inistration in rhesus macaques

@nl

P1476

Improved CNS exposure to tocil ...... inistration in rhesus macaques

@en

P2093

Brigitte C Widemann

http://www.w3.org/2001/XMLSchema#string

Cynthia M Lester McCully

http://www.w3.org/2001/XMLSchema#string

Daniel W Lee

http://www.w3.org/2001/XMLSchema#string

Katherine E Warren

http://www.w3.org/2001/XMLSchema#string

Nalini Jayaprakash

http://www.w3.org/2001/XMLSchema#string

Rafael Cruz Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Current concepts in the diagnosis and management of cytokine release syndrome.

Managing cytokine release syndrome associated with novel T cell-engaging therapies.

Development of a cerebrospinal fluid lateral reservoir model in rhesus monkeys (Macaca mulatta)

Minimally Invasive Lumbar Port System for the Collection of Cerebrospinal Fluid from Rhesus Macaques (Macaca mulatta)

Tocilizumab in the treatment of rheumatoid arthritis and beyond.

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia.

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

Tocilizumab: a novel humanized anti-interleukin 6 receptor antibody for the treatment of patients with rheumatoid arthritis

P304

662-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2018-05-846428

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Anandani Nellan

P577

2018-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29954750

http://www.w3.org/2001/XMLSchema#string

P921

immunology

hematology

cell biology

P932

6086204

http://www.w3.org/2001/XMLSchema#string